Stephen J. Tulipano
Overview
Stephen J. Tulipano received an average of $2M in total compensation, including $437K in salary, at Stoke Therapeutics from 2021 to 2023. Stephen Tulipano also received an average of $798K at Aldeyra Therapeutics from 2015 to 2018.
- Stoke Therapeutics
- Aldeyra Therapeutics
- 2023
- 2022
- 2021
- 2018
- 2017
- 2016
- 2015
Stoke TherapeuticsChief Financial Officer
Stoke TherapeuticsChief Financial Officer
Stoke TherapeuticsChief Financial Officer
Aldeyra Therapeuticsformer chief financial officer
Aldeyra TherapeuticsChief Financial Officer
Aldeyra TherapeuticsChief Financial Officer
Aldeyra TherapeuticsChief Financial Officer
Source: SEC filings on April 23, 2024, September 28, 2023, April 27, 2023, April 22, 2019, April 25, 2018, and April 24, 2017.
Related executives
We found nine more executives who work or worked at Stoke Therapeutics and Aldeyra Therapeutics.
Todd Brady
Aldeyra Therapeutics
Chief Executive Officer
Edward Kaye
Stoke Therapeutics
Chief Executive Officer
Barry Ticho
Stoke Therapeutics
Chief Medical Officer
Stephen Machatha
Aldeyra Therapeutics
Chief Development Officer
Bruce Greenberg
Aldeyra Therapeutics
Chief Financial Officer
Joshua Reed
Aldeyra Therapeutics
Chief Financial Officer
David Clark
Aldeyra Therapeutics
Chief Medical Officer
David McMullin
Aldeyra Therapeutics